Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Holme PA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 45
Tytuł:
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
Autorzy:
Enden T (AUTHOR)
Haig Y (AUTHOR)
Kløw NE (AUTHOR)
Slagsvold CE (AUTHOR)
Sandvik L (AUTHOR)
Ghanima W (AUTHOR)
Hafsahl G (AUTHOR)
Holme PA (AUTHOR)
Holmen LO (AUTHOR)
Njaastad AM (AUTHOR)
Sandbæk G (AUTHOR)
Sandset PM (AUTHOR)
CaVenT Study Group (CORPORATE AUTHOR)
Pokaż więcej
Źródło:
Lancet. 1/7/2012, Vol. 379 Issue 9810, p31-38. 8p.
Czasopismo naukowe
Szczegóły
Tytuł:
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management.
Autorzy:
Jørgensen OJ; Department of Otorhinolaryngology & Head and Neck Surgery Oslo University Hospital, Medical Faculty, University of Oslo Oslo Norway.
Steineger JE; Department of Otorhinolaryngology & Head and Neck Surgery Oslo University Hospital, Medical Faculty, University of Oslo Oslo Norway.
Hillarp A; Department of Translational Medicine Lund University Lund Sweden.; Department of Medical Biochemistry, Section for Haemostasis and Thrombosis Oslo University Hospital Oslo Norway.
Pareli Wåland E; Department of Medical Biochemistry, Section for Haemostasis and Thrombosis Oslo University Hospital Oslo Norway.
Holme PA; Department of Hematology Oslo University Hospital, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo Oslo Norway.
Heimdal K; Department of Medical Genetics Oslo University Hospital Oslo Norway.
Dheyauldeen S; Department of Otorhinolaryngology & Head and Neck Surgery Oslo University Hospital, Medical Faculty, University of Oslo Oslo Norway.
Pokaż więcej
Źródło:
Laryngoscope investigative otolaryngology [Laryngoscope Investig Otolaryngol] 2023 Dec 14; Vol. 9 (1), pp. e1196. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers.
Autorzy:
Matlary RED; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Grydeland M; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway.
Glosli H; Centre for Rare Disorders, Oslo University Hospital, Oslo, Norway.; Department of Paediatric Research, Oslo University Hospital, Oslo, Norway.
Rueegg CS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Mar; Vol. 29 (2), pp. 658-667. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/epidemiology
Male ; Humans ; Young Adult ; Adolescent ; Adult ; Exercise ; Walking ; Fitness Trackers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group.
Autorzy:
Klamroth R; Vivantes Klinikum im Friedrichshain, Berlin, Germany.
Ay C; Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
De Moerloose P; Faculty of Medicine, Geneva, Switzerland.
Fontana P; Division of Angiology and Hemostasis, University Hospitals of Geneva, Geneva, Switzerland.
Windyga J; Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Astermark J; Skåne University Hospital, Malmö, Sweden.
Berntorp E; Lund University, Malmö, Sweden.
Carvalho M; Congenital Coagulopathies Reference Center, Centro Hospitalar Universitário de São João, E.P.E., Porto, Portugal.
Dolan G; St Thomas' Hospital, London, United Kingdom.
Hermans C; St-Luc University Hospital, Brussels, Belgium.
Holme PA; Oslo University Hospital, Oslo, Norway.
Kenet G; Sheba Medical Center, Tel Hashomer & The Amalia Biron Thrombosis Research Institute, Tel Aviv University, Israel.
Mancuso ME; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Marquardt N; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
Nunez R; Virgen del Rocío Hospital, Seville, Spain.
Pabinger I; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
Rodgers R; Glasgow Royal Infirmary, Glasgow, UK.
Valk PV; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, University of Utrecht, The Netherlands.
Yuste VJ; Hospital Universitario La Paz, Autónoma University, Madrid, Spain.
Zupan IP; University Medical Centre Ljubljana, Department of Haematology, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Jan; Vol. 29 (1), pp. 21-32. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Acute Coronary Syndrome*/therapy
Acute Coronary Syndrome*/drug therapy
Hemophilia A*/complications
Hemophilia A*/drug therapy
Cardiology*
Humans ; Aged ; Consensus ; Delphi Technique ; Anticoagulants/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia.
Autorzy:
Matlary RED; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Glosli H; Centre for Rare Disorders, Oslo University Hospital, Oslo, Norway.; Department of Paediatric Research, Oslo University Hospital, Oslo, Norway.
Rueegg CS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Grydeland M; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Nov; Vol. 28 (6), pp. e172-e180. Date of Electronic Publication: 2022 Jul 13.
Typ publikacji:
Journal Article
MeSH Terms:
Fitness Trackers*
Hemophilia A*
Humans ; Adolescent ; Young Adult ; Adult ; Accelerometry ; Reproducibility of Results ; Exercise
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries.
Autorzy:
Lehtinen AE; Coagulation Disorders Unit, Department of Haematology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
Baghaei F; Coagulation Centre, Department of Medicine/Section of Haematology and Coagulation, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Astermark J; Institution for Translational Medicine, Lund University and Department for Haematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden.
Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Sep; Vol. 28 (5), pp. 713-719. Date of Electronic Publication: 2022 May 16.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/drug therapy
Hemophilia A*/surgery
Hemophilia B*/drug therapy
Hemophilia B*/surgery
Child ; Factor IX/therapeutic use ; Factor VIII/therapeutic use ; Half-Life ; Hemorrhage/drug therapy ; Humans ; Recombinant Fusion Proteins/pharmacology ; Recombinant Fusion Proteins/therapeutic use ; Recombinant Proteins/therapeutic use ; Retrospective Studies ; Scandinavian and Nordic Countries ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Platelet function testing: Current practice among clinical centres in Northern Europe.
Autorzy:
Szanto T; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, Helsinki University, Helsinki, Finland.
Zetterberg E; Department of Translational Medicine & Centre for Thrombosis and Haemostasis, Lund University, Malmö, Sweden.
Ramström S; Department of Clinical Chemistry and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.; School of Medical Sciences, Örebro University, Örebro, Sweden.
Leinøe EB; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Antovic JP; Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institute & Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Holmström M; Department of Health and Department of Acute Internal Medicine and Geriatrics, Medicine and Caring Sciences Linköping University, Linköping, Sweden.
Onundarson PT; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Pikta M; Laboratory, North Estonia Medical Centre, Tallinn, Estonia.
Vaide I; Department of Hemato-Oncology, University of Tartu, Institute of Clinical Medicine, Tartu, Estonia.
Olsson A; Region Västra Götaland, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Magnusson M; Department of Haematology and Coagulation Disorders, Sahlgrenska University Hospital, Gothenburg, Sweden.
Kärkkäinen S; Hemostasis and Platelet Laboratory, Fimlab Laboratoriot, Tampere, Finland.
Bitar M; Department of Laboratory Medicine, Clinical Chemistry, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden.
Poulsen LH; Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus, Denmark.
Lassila R; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, Helsinki University, Helsinki, Finland.
Pokaż więcej
Corporate Authors:
Nordic Haemophilia Council; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. 642-648. Date of Electronic Publication: 2022 May 05.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Platelet Disorders*/diagnosis
von Willebrand Diseases*/diagnosis
Blood Platelets ; Europe ; Hemorrhage/diagnosis ; Humans ; Platelet Function Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology.
Autorzy:
Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Medicine, Thrombosis Research and Expertise Center (TREC), UiT-The Arctic University of Norway, Tromsø, Norway.
Hausberg I; Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromsø, Norway.
Mørtberg TV; Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromsø, Norway.
Dahl TB; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Division of Emergencies and Critical Care, Department of Research and Development, Oslo University Hospital, Oslo, Norway.
Lerum TV; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Michelsen A; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ranheim T; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Nezvalova Henriksen K; South-Eastern Norway Enterprise, Oslo University Hospital and Hospital Pharmacies, Oslo, Norway.
Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Holme PA; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway.
Aaløkken TM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Skjønsberg OH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Barratt-Due A; Division of Emergencies and Critical Care, Department of Research and Development, Oslo University Hospital, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Ahlén MT; Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromsø, Norway.
Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Platelets [Platelets] 2022 May 19; Vol. 33 (4), pp. 640-644. Date of Electronic Publication: 2022 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Thrombocytopenia*/diagnosis
Anticoagulants/adverse effects ; Ferritins/adverse effects ; Heparin/adverse effects ; Humans ; Inflammation ; Osteopontin/adverse effects ; Platelet Factor 4 ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
Autorzy:
Holstein K; II. Medical Department, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Le Quellec S; Unité d'hémostase Clinique - Hôpital Cardiologique Louis Pradel - Hospices Civils de Lyon, Lyon, France.
Klamroth R; Department for Internal Medicine - vascular medicine and coagulation disorders at the Vivantes Hospital im Friedrichshain, Berlin, Germany.
Batorova A; National Hemophilia Centre, Dept. of Hematology and Transfusion Medicine, Faculty of Medicine of Comenius University and University Hospital, Bratislava, Slovakia.
Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Jiménez-Yuste V; Servicio de Hematología, Hospital Universitario La Paz, Paseo de la Castellana, Autónoma University, Madrid, Spain.
Astermark J; Department for Translational Medicine, Lund University and Department for Hematology Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Mar; Vol. 28 (2), pp. 215-222. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Bispecific*/pharmacology
Antibodies, Bispecific*/therapeutic use
Hemophilia A*/complications
Antibodies, Monoclonal, Humanized ; Factor VIII ; Humans ; Immune Tolerance
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81-8973.
Autorzy:
Arvanitakis A; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Berntorp E; Department of Translational Medicine, Lund University, Malmö, Sweden.
Astermark J; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Mar; Vol. 28 (2), pp. 223-229. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Factor VIII*/pharmacokinetics
Hemophilia A*/drug therapy
Half-Life ; Hemarthrosis ; Humans ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bone mineral density in haemophilia - a multicentre study evaluating the impact of different replacement regimens.
Autorzy:
Klintman J; Department of Translational Medicine, Clinical Coagulation Research Unit, Lund University, Malmö, Sweden.
Akesson KE; Department of Orthopedics, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Clinical and Molecular Osteoporosis Research Unit, Lund University, Malmö, Sweden.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical medicine, University of Oslo, Oslo, Norway.
Fischer K; Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Mar; Vol. 28 (2), pp. 239-246. Date of Electronic Publication: 2022 Jan 07.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/drug therapy
Hemophilia B*/complications
Hemophilia B*/drug therapy
Osteoporosis*/complications
Osteoporosis*/prevention & control
Adult ; Bone Density ; Case-Control Studies ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation.
Autorzy:
Måseide RJ; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Berntorp E; Department of Translational Medicine, Lund University, Malmö, Sweden.
Nummi V; Coagulation Disorders Unit, Haematology, Comprehensive Cancer Centre, Helsinki University Hospital, and Research Program in Systems Oncology, Faculty of Medicine, Helsinki University, Helsinki, Finland.
Lassila R; Coagulation Disorders Unit, Haematology, Comprehensive Cancer Centre, Helsinki University Hospital, and Research Program in Systems Oncology, Faculty of Medicine, Helsinki University, Helsinki, Finland.
Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Sep; Vol. 27 (5), pp. 793-801. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Hemophilia A*/diagnosis
Hemophilia B*/diagnosis
Cross-Sectional Studies ; Factor VIII ; Humans ; Phenotype ; Thrombelastography ; Thrombin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery.
Autorzy:
Jiménez-Yuste V; Department of Hematology, La Paz University Hospital-IdiPaz, Autónoma University, Madrid, Spain.
Rodríguez-Merchán EC; Osteoarticular Surgery Research, La Paz University Hospital-IdiPaz, Autónoma University, Madrid, Spain.
Matsushita T; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
Holme PA; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Jul; Vol. 27 (4), pp. 519-530. Date of Electronic Publication: 2021 May 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antibodies, Bispecific*
Hemophilia A*/complications
Hemophilia A*/drug therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Factor VIII/therapeutic use ; Hemorrhage/prevention & control ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
Autorzy:
Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN, USA.
Pabinger I; University Clinic for Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Poulsen L; The Haemophilia Centre, Aarhus University Hospital, Aarhus, Denmark.
Negrier C; Hemophilia Comprehensive Care Center and Hematology Department, Louis Pradel University Hospital, Lyon, France.
Chalasani P; Division of Hematology and Oncology, University of Arizona Cancer Center, Phoenix, AZ, USA.
Maas Enriquez M; Bayer, Wuppertal, Germany.
Wang M; Bayer, Whippany, NJ, USA.
Meijer K; University Medical Center Groningen, Groningen, Netherlands.
Mancuso ME; Center for Thrombosis and Haemorrhagic Diseases, IRCCS Humanitas Clinical and Research Center, Rozzano, Italy.
Lalezari S; National Haemophilia Centre, Chaim Sheba Medical Centre, Tel Aviv University, Tel Hashomer, Israel.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. e347-e356. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:
Factor VIII*/therapeutic use
Hemophilia A*/drug therapy
Polyethylene Glycols*/therapeutic use
Humans ; Male ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study.
Autorzy:
Måseide RJ; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Berntorp E; Department of Translational Medicine, Lund University, Malmö, Sweden.
Astermark J; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Skåne University Hospital, Malmö, Sweden.
Hansen J; Rehabilitation Unit, Emergency care/Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Olsson A; Department of Medicine, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Bruzelius M; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
Frisk T; Pediatric Coagulation, Karolinska University Hospital, Stockholm, Sweden.
Aspdahl M; Function Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
Nummi V; Coagulation Disorders Unit, Haematology, Comprehensive Cancer Centre, Helsinki University Hospital and Research Program in Systems Oncology, Faculty of Medicine, Helsinki University, Helsinki, Finland.
Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Mar; Vol. 27 (2), pp. e253-e259. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Arthritis*
Hemophilia A*/complications
Joint Diseases*/diagnosis
Joint Diseases*/diagnostic imaging
Cross-Sectional Studies ; Humans ; Ultrasonography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Management of comorbidities in haemophilia.
Autorzy:
Kempton CL; Department of Hematology and Medical Oncology and Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Emory University School of Medicine, Atlanta, GA, USA.
Makris M; Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Feb; Vol. 27 Suppl 3, pp. 37-45. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*/epidemiology
Hemophilia A*/complications
Hemophilia A*/epidemiology
Hepatitis C*/complications
Hepatitis C*/epidemiology
Comorbidity ; Humans ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
Autorzy:
Gorkom BL; Department of Hematology and Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Radboud University Medical Center, Nijmegen, The Netherlands.
Holme PA; Department of Hematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Joch C; CSL Behring, Marburg, Germany.
Rogosch T; CSL Behring, Marburg, Germany.
Feussner A; CSL Behring, Marburg, Germany.
McKeand W; CSL Behring, King of Prussia, USA.
Roberts J; CSL Behring, King of Prussia, USA.
van Heerde W; Department of Hematology and Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Laboratory Medicine, Hematology Laboratory, Radboud University Medical Center, Nijmegen, Netherlands.; Enzyre, Novio Tech Campus, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2020 Dec; Vol. 25 (1), pp. 17-25.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Factor VII Deficiency/*drug therapy
Factor VIIa/*therapeutic use
Adult ; Blood Coagulation/drug effects ; Factor VII Deficiency/blood ; Factor VIIa/adverse effects ; Factor VIIa/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Recombinant Fusion Proteins/adverse effects ; Recombinant Fusion Proteins/blood ; Recombinant Fusion Proteins/pharmacology ; Recombinant Fusion Proteins/therapeutic use ; Recombinant Proteins/adverse effects ; Recombinant Proteins/blood ; Recombinant Proteins/pharmacology ; Recombinant Proteins/therapeutic use ; Serum Albumin, Human/adverse effects ; Serum Albumin, Human/analysis ; Serum Albumin, Human/pharmacology ; Serum Albumin, Human/therapeutic use ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study.
Autorzy:
Måseide RJ; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Berntorp E; Department of Translational Medicine, Lund University, Malmö, Sweden.
Astermark J; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Skåne University Hospital, Malmö, Sweden.
Olsson A; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Bruzelius M; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
Frisk T; Pediatric Coagulation, Karolinska University Hospital, Stockholm, Sweden.
Nummi V; Coagulation Disorders Unit, Haematology, Comprehensive Cancer Centre, Helsinki University Hospital and Research Program in Systems Oncology, Faculty of Medicine, Helsinki University, Helsinki, Finland.
Lassila R; Coagulation Disorders Unit, Haematology, Comprehensive Cancer Centre, Helsinki University Hospital and Research Program in Systems Oncology, Faculty of Medicine, Helsinki University, Helsinki, Finland.
Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Sep; Vol. 26 (5), pp. 891-897. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Hemophilia A/*therapy
Hemophilia B/*therapy
Adolescent ; Adult ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Sweden ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 45

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies